Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer

References

• DingYQiaoYWangMEnhanced neuroprotection of acetyl-11-keto-β-boswellic acid (AKBA)-loaded O-carboxymethyl chitosan nanoparticles through antioxidant and anti-inflammatory pathwaysMol Neurobiol20165363842385326162321
   PubMed Web of Science ®Google Scholar
• HashemFMAl-SawahliMMNasrMAhmedOACustom fractional factorial designs to develop atorvastatin self-nanoemulsifying and nanosuspension delivery systems: enhancement of oral bioavailabilityDrug Des Devel Ther2015931413152
   PubMed Web of Science ®Google Scholar
• MancarellaSGrecoVBaldassarreFVergaraDMaffiaMLeporattiSPolymer-coated magnetic nanoparticles for curcumin delivery to cancer cellsMacromol Biosci201515101365137426085082
   PubMed Web of Science ®Google Scholar
• ShiFZhaoYFirempongCKXuXPreparation, characterization and pharmacokinetic studies of linalool-loaded nanostructured lipid carriersPharm Biol201654102320232826986932
   PubMed Web of Science ®Google Scholar
• ZhouJZhouDImprovement of oral bioavailability of lovastatin by using nanostructured lipid carriersDrug Des Devel Ther2015952695275
   PubMed Web of Science ®Google Scholar
• WuMFanYLvSXiaoBYeMZhuXVincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs deliveryDrug Deliv20162382720272526203691
   PubMed Web of Science ®Google Scholar
• SongASuZLiSHanFNanostructured lipid carriers-based flurbiprofen gel after topical administration: acute skin irritation, pharmacodynamics, and percutaneous absorption mechanismDrug Dev Ind Pharm20154191488149225231972
   PubMed Web of Science ®Google Scholar
• ZhangCPengFLiuWNanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male ratsInt J Nanomedicine201491049106324591827
   PubMed Web of Science ®Google Scholar
• HanFYinRCheXNanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluationInt J Pharm2012439134935722989987
   PubMedGoogle Scholar
• SongJFanXShenQDaidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal deliveryInt J Pharm2016501124525226851353
   PubMedGoogle Scholar
• LiuXWangZFengRHuYHuangGA novel approach for systematic delivery of a hydrophobic anti-leukemia agent tamibarotene mediated by nanostructured lipid carrierJ Biomed Nanotechnol2013991586159323980506
   PubMedGoogle Scholar
• RanpiseNSKorabuSSGhodakeVNSecond generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochlorideColloids Surf B Biointerfaces2014116818724445002
   PubMed Web of Science ®Google Scholar
• GuXZhangWLiuJPreparation and characterization of a lovastatin-loaded protein-free nanostructured lipid carrier resembling high-density lipoprotein and evaluation of its targeting to foam cellsAAPS PharmSciTech20111241200120821927961
   PubMed Web of Science ®Google Scholar
• BaykaraMCoskunUBerkVGemcitabine plus paclitaxel as second-line chemotherapy in patients with advanced non-small cell lung cancerAsian Pac J Cancer Prev201213105119512423244121
   PubMedGoogle Scholar
• KroepJRSmitEFGiacconeGPharmacology of the paclitaxelcisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancerCancer Chemother Pharmacol200658450951616523337
   PubMedGoogle Scholar
• ShordSSFaucetteSRGillenwaterHHGemcitabine pharmacokinetics and interaction with paclitaxel in patients with advanced non-small-cell lung cancerCancer Chemother Pharmacol200351432833612721761
   PubMed Web of Science ®Google Scholar
• FogliSDanesiRDe BraudFDrug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancerAnn Oncol200112111553155911822754
   PubMedGoogle Scholar
• MiaoLGuoSZhangJKimWYHuangLNanoparticles with precise ratiometric co-loading and co-delivery of gemcitabine monophosphate and cisplatin for treatment of bladder cancerAdv Funct Mater201424426601661125395922
   PubMed Web of Science ®Google Scholar
• KroepJRGiacconeGTolisCSequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell linesBr J Cancer20008381069107610993656
   PubMed Web of Science ®Google Scholar
• TardiPGDos SantosNHarasymTODrug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivoMol Cancer Ther2009882266227519671743
   PubMed Web of Science ®Google Scholar
• DuanXXiaoJYinQSmart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiramACS Nano2013775858586923734880
   PubMed Web of Science ®Google Scholar
• DingYHanJTianBHepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug deliveryInt J Pharm2014477118719625455771
   PubMedGoogle Scholar
• PawarSVaviaPGlucosamine anchored cancer targeted nanovesicular drug delivery system of doxorubicinJ Drug Target2016241687926152812
   PubMed Web of Science ®Google Scholar
• MachedaMLRogersSBestJDMolecular and cellular regulation of glucose transporter (GLUT) proteins in cancerJ Cell Physiol2005202365466215389572
   PubMed Web of Science ®Google Scholar
• PawarSKVaviPEfficacy interactions of PEG-DOX-N-acetyl glucosamine prodrug conjugate for anticancer therapyEur J Pharm Biopharm201597Pt B45446326614563
   PubMedGoogle Scholar
• PawarSKBadhwarAJKharasFKhandareJJVaviaPRDesign, synthesis and evaluation of N-acetyl glucosamine (NAG)-PEG-doxorubicin targeted conjugates for anticancer deliveryInt J Pharm2012436118319322721850
   PubMedGoogle Scholar
• GuXZhangWLiuJPreparation and characterization of a lovastatin-loaded protein-free nanostructured lipid carrier resembling high-density lipoprotein and evaluation of its targeting to foam cellsAAPS PharmSciTech20111241200120821927961
   PubMed Web of Science ®Google Scholar
• CavallaroGLicciardiMCalicetiPSalmasoSGiammonaGSynthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrugEur J Pharm Biopharm200458115115915207549
   PubMedGoogle Scholar
• CavallaroGLicciardiMSalmasoSCalicetiPGaetanoGFolatemediated targeting of polymeric conjugates of gemcitabineInt J Pharm2006307225826916298091
   PubMed Web of Science ®Google Scholar
• WangYHongCYPanCYGalactose-based amphiphilic block copolymers: synthesis, micellization, and bioapplicationBiomacromolecules20131451444145123557092
   PubMedGoogle Scholar
• ChouTCTheoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studiesPharmacol Rev200658362168116968952
   PubMed Web of Science ®Google Scholar
• DeutschHMGlinskiJAHernandezMSynthesis of congeners and prodrugs – 3: water-soluble prodrugs of taxol with potent antitumor activityJ Med Chem19893247887922564894
   PubMedGoogle Scholar
• GuoZWGalloJMSelective protection of 2′,2′-difluorodeoxycytidine (gemcitabine)J Org Chem199964228319832211674754
   PubMedGoogle Scholar
• LvSTangZLiMCo-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancerBiomaterials201435236118612924794923
   PubMed Web of Science ®Google Scholar
• LvSTangZZhangDWell-defined polymer-drug conjugate engineered with redox and pH-sensitive release mechanism for efficient delivery of paclitaxelJ Control Release201419422022725220162
   PubMed Web of Science ®Google Scholar
• YangQYangYLiLPolymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancerACS Appl Mater Interfaces20157126661667325775367
   PubMedGoogle Scholar
• LeeSMO’HalloranTVNguyenSTPolymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapyJ Am Chem Soc201013248171301713821077673
   PubMedGoogle Scholar
• LuoSGuYZhangYPrecise ratiometric control of dual drugs through a single macromolecule for combination therapyMol Pharm20151272318232726035636
   PubMedGoogle Scholar
• MayerLDHarasymTOTardiPGRatiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing miceMol Cancer Ther2006571854186316891472
   PubMed Web of Science ®Google Scholar
• KrishnamurthySNgVWGaoSTanMHYangYYPhenformin-loaded polymeric micelles for targeting both cancer cells and cancer stem cells in vitro and in vivoBiomaterials201435339177918625106770
   PubMedGoogle Scholar
• YooHSParkTGBiodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymerJ Control Release2001701637011166408
   PubMedGoogle Scholar
• XuXYLuLZhouJPPreparation and characterization of N-succinyl-N′-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activityColloids Surf B Biointerfaces200755222222817254755
   PubMedGoogle Scholar
• LiuYFangJKimYJWongMKWangPCodelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activityMol Pharm20141151651166124673622
   PubMed Web of Science ®Google Scholar
• JiaJZhuFMaXMechanisms of drug combinations: interaction and network perspectivesNat Rev Drug Discov20098211112819180105
   PubMed Web of Science ®Google Scholar
• TannockIFRotinDAcid pH in tumors and its potential for therapeutic exploitationCancer Res19894916437343842545340
   PubMed Web of Science ®Google Scholar